Skip to content
Home/Companies/Biotech/Ciphergen Biosystems

Ciphergen Biosystems

Biotech·US·Exited 2000·Held under 1yr
Entry
2000
Hold
<1yr
Exit
2000

Who owns Ciphergen Biosystems?

Ciphergen Biosystems was owned by Amadeus Capital Partners through Amadeus II Technology Fund (2000 vintage) from 2000 to 2000, exited via IPO.

Hand-verified · updated 2026-07-24

Amadeus Capital Partners
Investor
Amadeus Capital Partners
Amadeus II Technology Fund · 2000

Key facts

HQUS
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2000

More from Amadeus II Technology Fund

Other portfolio companies in the same fund.

Optos
Exited 2015
MedTechUK
to
Openbravo
Openbravo
Exited 2022
SoftwareSpain· 2008
to
Icera
Exited 2011
Deep TechUK· 2006
to
Forescout
Exited 2017
CybersecurityUS· 2005
Aepona
Exited 2013
SoftwareUK· 2003
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Inits Group
Inits Group
Active
Sofilaro GestionFrance
Track Ciphergen Biosystems

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Ciphergen Biosystems.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue